Sedana Medical AB’s Interim report January-March 2023
Back to growthFirst quarter 2023 · Net sales for the quarter totalled MSEK 37.8 (33.7), equivalent to an increase of 12% compared to 2022. At constant exchange rates, sales increased by 5%. · Gross profit was MSEK 27.5 (23.0) equivalent to a margin of 73% (68%). · Earnings before interest, taxes, depreciation and amortisation (EBITDA) totalled MSEK -10.7 (-16.4), equivalent to an EBITDA margin of -28% (-49%). · Operating income (EBIT) totalled MSEK -16.3 (-22.1), equivalent to an EBIT margin of -43% (-66%). · Net income for the quarter was MSEK -16.1 (-19.0) and earnings